CenterWatch

Clinical Trial Details

Overview

Research Study Summary

New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)

Purpose

This is a 12 week treatment study to evaluate the efficacy of two doses of new medication compared to placebo in lowering pain intensity in patients with PHN. There is also a 9 month follow - up period for a total duration of 12 months.

Patient Inclusion Criteria:

  • Ages 18-80
  • Persistant PHN pain for a minimum of 9 months following the onset of a herpes zoster skin rash (shingles)
  • Must be willing to wash out of chronic pain medication for the 12 week treatment period.

Patient Exclusion Criteria:

  • Must not have any other neuropathic pain

To Learn more

CW ID: 183365
Date Last Changed: July 16, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
18 to 80 Years
Overall Status
Recruiting
Duration
12 Months
Facility Type
N/A

Contact

Alpine Clinical Research Center
1000 Alpine Avenue, Suite 200
Boulder, CO 80304
Phone: 303-443-7229

View Map

Research Center Information: Alpine Clinical Research Center

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.